Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
IGC Pharma, Inc. Common Stock
(NY:
IGC
)
0.3000
-0.0361 (-10.74%)
Official Closing Price
Updated: 8:00 PM EST, Dec 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IGC Pharma, Inc. Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
June 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
The Future Of The Indian Market
↗
June 19, 2022
India has an estimated 26,000 startups, making it the third-largest startup ecosystem in the world, recording consolidated inflows of over $36 billion in the past 3 years.
Via
Talk Markets
91 Biggest Movers From Friday
↗
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
44 Stocks Moving In Friday's Mid-Day Session
↗
June 10, 2022
Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
↗
June 09, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.
Via
Benzinga
69 Biggest Movers From Yesterday
↗
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
IGC Receives U.S. Patent For Method And Composition For Treating Seizure Disorders, Utilizing CBD
↗
June 09, 2022
United States Patent and Trademark Office issued a patent (#11,351,152) to the India Globalization Capital, Inc. (AMEX:IGC) titled “Method and Composition for Treating Seizure Disorders.”
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
June 09, 2022
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
↗
June 09, 2022
Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.
Via
Benzinga
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
June 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
83 Biggest Movers From Yesterday
↗
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
June 03, 2022
Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits
April 18, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
36 Stocks Moving In Friday's Mid-Day Session
↗
March 25, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported...
Via
Benzinga
64 Biggest Movers From Friday
↗
March 28, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...
Via
Benzinga
34 Stocks Moving in Friday's Pre-Market Session
↗
March 25, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...
Via
Benzinga
Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week
↗
March 24, 2022
The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressi...
Via
Benzinga
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors
March 23, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
India Globalization Capital Posts Net Loss Of $2.38M For The Third Quarter
↗
February 11, 2022
India Globalization Capital, Inc. (AMEX:IGC) announced its financial results for the three months ending December 31, 2021 – quarter three of the company’s 2022 fiscal year. Q3 Financial Highlights
Via
Benzinga
IGC Reports Financial Results for the December 31, 2021 Quarter
February 10, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
January 19, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
↗
December 14, 2021
India Globalization Capital, Inc. (NYSE: IGC) announced Tuesday that it had received positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a...
Via
Benzinga
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
December 14, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
↗
December 09, 2021
India Globalization Capital, Inc. (AMEX:IGC) revealed th...
Via
Benzinga
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
December 08, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
December 02, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth
↗
December 01, 2021
Former prime minister of Israel and InterCure chairman Ehud Barak at the company’s market open from their cultivation site in Israel...
Via
Benzinga
Topics
Cannabis
IGC Posts Q2 Results, Reveals Promising Results From Clinical Trial Of THC-Drug For Alzheimer's Symptoms
↗
November 01, 2021
India Globalization Capital, Inc. (AMEX:
Via
Benzinga
IGC Reports Financial Results for the September 30, 2021 Quarter
October 29, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Announces Results of its 2021 Annual Stockholders Meeting
October 15, 2021
From
India Globalization Capital, Inc.
Via
Business Wire
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.